Cheng Hu
Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Basic Helix-Loop-Helix Transcription Factors | 14 | 2019 | 243 | 3.140 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 15 | 2023 | 278 | 2.770 |
Why?
| | Hypertension, Pulmonary | 15 | 2025 | 1910 | 2.380 |
Why?
| | Transcriptional Activation | 10 | 2018 | 378 | 1.550 |
Why?
| | Hypoxia | 13 | 2024 | 1112 | 1.240 |
Why?
| | Upstream Stimulatory Factors | 3 | 2013 | 8 | 0.850 |
Why?
| | Gene Expression Regulation | 11 | 2021 | 2607 | 0.810 |
Why?
| | Cell Hypoxia | 10 | 2014 | 226 | 0.780 |
Why?
| | STAT3 Transcription Factor | 2 | 2013 | 206 | 0.720 |
Why?
| | Fibroblasts | 8 | 2025 | 996 | 0.680 |
Why?
| | Transcription Factors | 6 | 2013 | 1719 | 0.650 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2020 | 261 | 0.630 |
Why?
| | Pulmonary Artery | 4 | 2024 | 1086 | 0.620 |
Why?
| | Disease Susceptibility | 1 | 2021 | 347 | 0.610 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2020 | 446 | 0.560 |
Why?
| | MicroRNAs | 2 | 2021 | 692 | 0.530 |
Why?
| | Signal Transduction | 8 | 2024 | 5079 | 0.520 |
Why?
| | Cells, Cultured | 10 | 2025 | 4193 | 0.500 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 422 | 0.500 |
Why?
| | RNA Splicing | 2 | 2014 | 269 | 0.480 |
Why?
| | Endothelial Cells | 7 | 2024 | 785 | 0.470 |
Why?
| | Animals | 34 | 2025 | 36940 | 0.450 |
Why?
| | Adrenomedullin | 1 | 2014 | 5 | 0.440 |
Why?
| | Hypoxia-Inducible Factor 1 | 2 | 2013 | 72 | 0.410 |
Why?
| | Alternative Splicing | 2 | 2017 | 229 | 0.410 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 104 | 0.390 |
Why?
| | DNA Helicases | 1 | 2013 | 145 | 0.370 |
Why?
| | Vascular Remodeling | 3 | 2024 | 193 | 0.360 |
Why?
| | Trans-Activators | 3 | 2007 | 398 | 0.340 |
Why?
| | Nuclear Proteins | 3 | 2013 | 712 | 0.340 |
Why?
| | Respirovirus | 2 | 2000 | 6 | 0.330 |
Why?
| | Promoter Regions, Genetic | 8 | 2013 | 1250 | 0.310 |
Why?
| | Cell Proliferation | 7 | 2020 | 2475 | 0.310 |
Why?
| | Mice | 22 | 2024 | 17787 | 0.300 |
Why?
| | Erythropoietin | 4 | 2014 | 95 | 0.280 |
Why?
| | Phosphoproteins | 2 | 2000 | 338 | 0.270 |
Why?
| | Mice, Knockout | 8 | 2019 | 3015 | 0.270 |
Why?
| | Cell Line, Tumor | 6 | 2014 | 3412 | 0.270 |
Why?
| | Viral Proteins | 2 | 2000 | 342 | 0.270 |
Why?
| | Cattle | 7 | 2025 | 984 | 0.260 |
Why?
| | Transfection | 4 | 2014 | 945 | 0.260 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2023 | 382 | 0.240 |
Why?
| | Stem Cells | 2 | 2006 | 594 | 0.230 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 976 | 0.230 |
Why?
| | Complement System Proteins | 2 | 2025 | 327 | 0.220 |
Why?
| | Phenotype | 4 | 2023 | 3196 | 0.220 |
Why?
| | Humans | 30 | 2025 | 137585 | 0.210 |
Why?
| | Cell Line | 7 | 2013 | 2847 | 0.200 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2023 | 145 | 0.200 |
Why?
| | Sirtuin 3 | 1 | 2023 | 61 | 0.200 |
Why?
| | Cell Survival | 3 | 2014 | 1120 | 0.200 |
Why?
| | Transcription, Genetic | 4 | 2021 | 1457 | 0.200 |
Why?
| | Gene Knockdown Techniques | 2 | 2014 | 327 | 0.190 |
Why?
| | Histone Deacetylase Inhibitors | 2 | 2021 | 210 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-rel | 1 | 2001 | 9 | 0.190 |
Why?
| | RNA, Messenger | 6 | 2020 | 2833 | 0.180 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2021 | 91 | 0.170 |
Why?
| | HEK293 Cells | 2 | 2013 | 730 | 0.170 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 84 | 0.170 |
Why?
| | Receptors, Notch | 2 | 2014 | 88 | 0.170 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2023 | 238 | 0.160 |
Why?
| | Respirovirus Infections | 1 | 1999 | 13 | 0.160 |
Why?
| | Macrophage Activation | 1 | 2021 | 201 | 0.160 |
Why?
| | RNA Polymerase II | 2 | 2013 | 324 | 0.160 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2020 | 60 | 0.160 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2020 | 92 | 0.160 |
Why?
| | Histone Deacetylases | 1 | 2021 | 215 | 0.160 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2014 | 1396 | 0.150 |
Why?
| | Culture Media, Conditioned | 3 | 2023 | 110 | 0.150 |
Why?
| | Proto-Oncogene Proteins | 1 | 2001 | 648 | 0.140 |
Why?
| | Protein Binding | 4 | 2014 | 2224 | 0.140 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 391 | 0.140 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 17 | 0.140 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2017 | 17 | 0.140 |
Why?
| | Pyruvate Kinase | 1 | 2017 | 29 | 0.140 |
Why?
| | Interferon Type I | 2 | 1996 | 140 | 0.140 |
Why?
| | Mice, Inbred C57BL | 4 | 2023 | 5757 | 0.140 |
Why?
| | DNA-Binding Proteins | 2 | 2002 | 1502 | 0.130 |
Why?
| | Chromatin | 1 | 2021 | 519 | 0.130 |
Why?
| | Virus Replication | 1 | 1999 | 483 | 0.130 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4295 | 0.130 |
Why?
| | Glycolysis | 3 | 2025 | 321 | 0.130 |
Why?
| | Embryonic Stem Cells | 2 | 2007 | 129 | 0.120 |
Why?
| | B-Lymphocytes | 1 | 2001 | 847 | 0.120 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2526 | 0.120 |
Why?
| | Response Elements | 2 | 2014 | 91 | 0.120 |
Why?
| | RNA Interference | 2 | 2017 | 469 | 0.120 |
Why?
| | Histones | 1 | 2021 | 636 | 0.120 |
Why?
| | Gene Expression | 3 | 2020 | 1502 | 0.120 |
Why?
| | Binding Sites | 2 | 2013 | 1303 | 0.120 |
Why?
| | Cytokines | 1 | 2023 | 2085 | 0.120 |
Why?
| | DNA Methylation | 1 | 2020 | 643 | 0.110 |
Why?
| | Interferon-beta | 1 | 1995 | 92 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 1081 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2486 | 0.110 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2014 | 80 | 0.110 |
Why?
| | 5' Untranslated Regions | 1 | 2014 | 58 | 0.110 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2013 | 4 | 0.110 |
Why?
| | Carbonic Anhydrase IX | 1 | 2013 | 4 | 0.110 |
Why?
| | Up-Regulation | 3 | 2020 | 843 | 0.110 |
Why?
| | Interferon-alpha | 1 | 1995 | 198 | 0.110 |
Why?
| | Angiopoietins | 1 | 2013 | 13 | 0.110 |
Why?
| | Carbonic Anhydrases | 1 | 2013 | 14 | 0.100 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 660 | 0.100 |
Why?
| | Cobalt | 1 | 2013 | 52 | 0.100 |
Why?
| | Kupffer Cells | 1 | 2013 | 50 | 0.100 |
Why?
| | Liver Regeneration | 1 | 2013 | 46 | 0.100 |
Why?
| | Cell Growth Processes | 1 | 2013 | 52 | 0.100 |
Why?
| | Rats | 2 | 2019 | 5647 | 0.100 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2014 | 107 | 0.100 |
Why?
| | Protein Interaction Maps | 1 | 2013 | 48 | 0.100 |
Why?
| | Breast Neoplasms | 3 | 2014 | 2253 | 0.100 |
Why?
| | Mutation | 4 | 2023 | 3958 | 0.100 |
Why?
| | Exons | 1 | 2014 | 355 | 0.100 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2006 | 767 | 0.100 |
Why?
| | Genes, Reporter | 1 | 2013 | 269 | 0.100 |
Why?
| | CREB-Binding Protein | 1 | 2012 | 31 | 0.100 |
Why?
| | p300-CBP Transcription Factors | 1 | 2012 | 26 | 0.100 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2012 | 327 | 0.100 |
Why?
| | Cellular Reprogramming | 2 | 2025 | 99 | 0.100 |
Why?
| | Cell Movement | 2 | 2013 | 967 | 0.090 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2013 | 137 | 0.090 |
Why?
| | Oxidative Stress | 1 | 2018 | 1317 | 0.090 |
Why?
| | Plasmids | 1 | 2012 | 363 | 0.090 |
Why?
| | Carcinogenesis | 1 | 2013 | 217 | 0.090 |
Why?
| | Antigens, Neoplasm | 1 | 2013 | 319 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1226 | 0.090 |
Why?
| | Carcinoma, Renal Cell | 1 | 2013 | 217 | 0.080 |
Why?
| | Oxygen | 2 | 2014 | 931 | 0.080 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2007 | 138 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2012 | 622 | 0.080 |
Why?
| | Biomarkers | 1 | 2021 | 4149 | 0.080 |
Why?
| | Macrophages | 2 | 2017 | 1547 | 0.080 |
Why?
| | Heart Failure | 1 | 2023 | 2236 | 0.080 |
Why?
| | Hypertension | 1 | 2018 | 1295 | 0.080 |
Why?
| | Antiviral Agents | 1 | 1995 | 744 | 0.080 |
Why?
| | Tumor Microenvironment | 1 | 2013 | 674 | 0.080 |
Why?
| | Lung | 4 | 2024 | 4060 | 0.070 |
Why?
| | Inflammation | 3 | 2025 | 2837 | 0.070 |
Why?
| | Kidney Neoplasms | 1 | 2013 | 403 | 0.070 |
Why?
| | Liver Neoplasms | 1 | 2013 | 786 | 0.070 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2006 | 17 | 0.060 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2006 | 18 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2007 | 139 | 0.060 |
Why?
| | Anemia | 1 | 2007 | 170 | 0.060 |
Why?
| | Phosphorylation | 2 | 2000 | 1759 | 0.060 |
Why?
| | Embryonic Development | 1 | 2006 | 119 | 0.060 |
Why?
| | Teratoma | 1 | 2006 | 114 | 0.060 |
Why?
| | Colonic Neoplasms | 1 | 2007 | 258 | 0.060 |
Why?
| | Liver | 1 | 2013 | 1943 | 0.060 |
Why?
| | Genetic Therapy | 2 | 1996 | 297 | 0.050 |
Why?
| | Complement C3 | 1 | 2025 | 209 | 0.050 |
Why?
| | Pericytes | 1 | 2024 | 34 | 0.050 |
Why?
| | Female | 7 | 2020 | 73304 | 0.050 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2023 | 52 | 0.050 |
Why?
| | Cricetinae | 3 | 2006 | 289 | 0.050 |
Why?
| | Mice, Nude | 4 | 2014 | 698 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 272 | 0.050 |
Why?
| | NAD | 1 | 2023 | 77 | 0.050 |
Why?
| | Down-Regulation | 2 | 2006 | 657 | 0.050 |
Why?
| | Repressor Proteins | 1 | 2006 | 427 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2007 | 1946 | 0.050 |
Why?
| | Interleukin-4 | 1 | 2023 | 216 | 0.050 |
Why?
| | Tumor Cells, Cultured | 3 | 1999 | 955 | 0.050 |
Why?
| | Aniline Compounds | 1 | 2023 | 102 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 111 | 0.050 |
Why?
| | Adaptive Immunity | 1 | 2023 | 165 | 0.050 |
Why?
| | Male | 4 | 2025 | 67762 | 0.050 |
Why?
| | Protein Isoforms | 2 | 2017 | 404 | 0.050 |
Why?
| | Interleukin-10 | 1 | 2023 | 302 | 0.040 |
Why?
| | CHO Cells | 2 | 2006 | 161 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2023 | 257 | 0.040 |
Why?
| | T-Lymphocyte Subsets | 1 | 2023 | 417 | 0.040 |
Why?
| | Ventricular Remodeling | 1 | 2023 | 266 | 0.040 |
Why?
| | Ventricular Function, Right | 1 | 2023 | 285 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2023 | 480 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 233 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2021 | 239 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2001 | 316 | 0.040 |
Why?
| | Cytochrome P450 Family 2 | 1 | 2020 | 12 | 0.040 |
Why?
| | Cardiovascular System | 1 | 2002 | 137 | 0.040 |
Why?
| | Bone Marrow Transplantation | 1 | 2001 | 286 | 0.040 |
Why?
| | Phosphopeptides | 1 | 2000 | 20 | 0.040 |
Why?
| | Base Sequence | 1 | 2003 | 2181 | 0.040 |
Why?
| | Blotting, Northern | 1 | 1999 | 201 | 0.040 |
Why?
| | HeLa Cells | 2 | 2006 | 636 | 0.040 |
Why?
| | Mice, Inbred ICR | 1 | 1999 | 119 | 0.040 |
Why?
| | Sequence Deletion | 1 | 2000 | 183 | 0.040 |
Why?
| | Spleen | 1 | 2001 | 514 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2023 | 614 | 0.040 |
Why?
| | Point Mutation | 1 | 2000 | 235 | 0.040 |
Why?
| | Neovascularization, Physiologic | 2 | 2013 | 179 | 0.040 |
Why?
| | Forkhead Box Protein M1 | 1 | 2018 | 7 | 0.040 |
Why?
| | Genome, Viral | 1 | 1999 | 144 | 0.040 |
Why?
| | Genetic Vectors | 2 | 1996 | 319 | 0.040 |
Why?
| | Antagomirs | 1 | 2017 | 12 | 0.040 |
Why?
| | Naphthoquinones | 1 | 2017 | 19 | 0.040 |
Why?
| | Heart Ventricles | 1 | 2023 | 788 | 0.030 |
Why?
| | Metabolome | 1 | 2021 | 350 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 801 | 0.030 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 181 | 0.030 |
Why?
| | Cell Division | 2 | 1996 | 794 | 0.030 |
Why?
| | Mitochondria | 1 | 2023 | 948 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2023 | 916 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2003 | 1774 | 0.030 |
Why?
| | Adenoviruses, Human | 1 | 1996 | 27 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1111 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2000 | 706 | 0.030 |
Why?
| | RNA, Viral | 1 | 1999 | 656 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2017 | 372 | 0.030 |
Why?
| | Dependovirus | 1 | 1996 | 68 | 0.030 |
Why?
| | Vero Cells | 1 | 1995 | 69 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 1996 | 176 | 0.030 |
Why?
| | Guinea Pigs | 1 | 1995 | 158 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 971 | 0.030 |
Why?
| | Cats | 1 | 1995 | 210 | 0.030 |
Why?
| | Interferons | 1 | 1996 | 202 | 0.030 |
Why?
| | Macaca mulatta | 1 | 1995 | 166 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 257 | 0.030 |
Why?
| | Phosphoglycerate Kinase | 1 | 2013 | 2 | 0.030 |
Why?
| | Amino Acids, Dicarboxylic | 1 | 2013 | 8 | 0.030 |
Why?
| | Deferoxamine | 1 | 2013 | 24 | 0.030 |
Why?
| | Dogs | 1 | 1995 | 413 | 0.030 |
Why?
| | Species Specificity | 1 | 1995 | 585 | 0.030 |
Why?
| | Rabbits | 1 | 1995 | 794 | 0.030 |
Why?
| | Receptors, CCR2 | 1 | 2013 | 40 | 0.030 |
Why?
| | Pyrrolidines | 1 | 2013 | 79 | 0.030 |
Why?
| | Propanolamines | 1 | 2013 | 96 | 0.030 |
Why?
| | Lung Diseases | 1 | 1999 | 767 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2014 | 810 | 0.020 |
Why?
| | Protein Subunits | 1 | 2013 | 239 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 1995 | 1353 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 346 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2017 | 927 | 0.020 |
Why?
| | Acetaminophen | 1 | 2013 | 268 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1272 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2013 | 620 | 0.020 |
Why?
| | Melanoma | 1 | 1996 | 760 | 0.020 |
Why?
| | Immunohistochemistry | 2 | 2006 | 1738 | 0.020 |
Why?
| | Protein Inhibitors of Activated STAT | 1 | 2007 | 6 | 0.020 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2007 | 16 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2007 | 24 | 0.020 |
Why?
| | Sp1 Transcription Factor | 1 | 2007 | 24 | 0.020 |
Why?
| | COUP Transcription Factor II | 1 | 2006 | 1 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2007 | 144 | 0.020 |
Why?
| | Erythropoiesis | 1 | 2007 | 55 | 0.020 |
Why?
| | Cricetulus | 1 | 2006 | 109 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2007 | 232 | 0.020 |
Why?
| | Transforming Growth Factor alpha | 1 | 2006 | 57 | 0.020 |
Why?
| | Feedback | 1 | 2006 | 173 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2007 | 175 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 2006 | 218 | 0.010 |
Why?
| | Arteries | 1 | 2006 | 269 | 0.010 |
Why?
| | Cell Cycle | 1 | 2007 | 601 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2006 | 430 | 0.010 |
Why?
| | Stress, Physiological | 1 | 2007 | 443 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2006 | 545 | 0.010 |
Why?
| | Models, Genetic | 1 | 2006 | 600 | 0.010 |
Why?
| | Alleles | 1 | 2006 | 891 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2006 | 617 | 0.010 |
Why?
| | von Hippel-Lindau Disease | 1 | 2002 | 12 | 0.010 |
Why?
| | Hematopoiesis | 1 | 2002 | 192 | 0.010 |
Why?
| | Models, Biological | 1 | 2006 | 1783 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2006 | 1991 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2002 | 860 | 0.010 |
Why?
| | Mesocricetus | 1 | 1996 | 39 | 0.010 |
Why?
| | Leukemia, Myeloid | 1 | 1996 | 45 | 0.010 |
Why?
| | Luciferases | 1 | 1996 | 150 | 0.010 |
Why?
| | Transplantation, Heterologous | 1 | 1996 | 194 | 0.010 |
Why?
| | Clone Cells | 1 | 1996 | 265 | 0.010 |
Why?
| | Placenta | 1 | 2002 | 750 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 1996 | 170 | 0.010 |
Why?
| | Pregnancy | 1 | 2006 | 6763 | 0.010 |
Why?
| | Zinc | 1 | 1996 | 297 | 0.010 |
Why?
| | Kinetics | 1 | 1996 | 1670 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1996 | 528 | 0.010 |
Why?
| | Kidney | 1 | 1996 | 1468 | 0.000 |
Why?
|
|
Hu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|